Current Cancer Drug Targets Explained

Editor:	Ruiwen Zhang
Discipline:	Oncology
Abbreviation:	Curr. Cancer Drug Targets
Publisher:	Bentham Science Publishers
Frequency:	11/year
History:	2001–present
Impact:	2.912
Impact-Year:	2019
Website:	https://benthamscience.com/journals/current-cancer-drug-targets/
Link1:	https://benthamscience.com/journals/current-cancer-drug-targets/
Link1-Name:	Online access
Link2:	https://benthamscience.com/journals/current-cancer-drug-targets/
Link2-Name:	Online archive
Oclc:	48132748
Coden:	CCDTB9
Issn:	1568-0096
Eissn:	1873-5576

Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").^[1]

Abstracting and indexing

Current Cancer Drug Targets is abstracted and indexed in:^[2]

• Chemical Abstracts Service/CASSI
• EMBASE
• EMBiology
• MEDLINE
• Science Citation Index Expanded
• Scopus

According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.912.^[3]

Notes and References

1. Web site: June 2021. Journal overview. 2021-06-14. Current Cancer Drug Targets. Bentham Science Publishers.
2. Web site: List of indexing services . Current Cancer Drug Targets . Bentham Science Publishers . June 2021 . 2011-08-04 . dead . https://web.archive.org/web/20110801233328/http://www.benthamscience.com/ccdt/index.htm . 2011-08-01 .
3. Book: 2019 Journal Citation Reports. Clarivate. 2020. Journals Ranked by Impact: Oncology. ..